Detalhe da pesquisa
1.
The prevalence and impact of polypharmacy in rheumatology.
Rheumatology (Oxford)
; 62(SI3): SI237-SI241, 2023 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871915
2.
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.
Rheumatology (Oxford)
; 62(6): 2122-2129, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282537
3.
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial.
Ann Rheum Dis
; 81(3): 351-358, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34815219
4.
Emerging injectable therapies for osteoarthritis.
Expert Opin Emerg Drugs
; 27(3): 311-320, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102303
5.
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE.
Rheumatology (Oxford)
; 60(12): 5583-5594, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590829
6.
Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis.
Rheumatology (Oxford)
; 59(9): 2217-2225, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32406509
7.
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response.
Ann Rheum Dis
; 78(11): 1454-1462, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362993
8.
Time to flare in giant cell arteritis and polymyalgia rheumatica: analysis from a single-centre Australian practice.
Intern Med J
; 54(5): 838-839, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757207
9.
Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial.
Rheumatology (Oxford)
; 57(1): 84-91, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29155973
10.
Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.
Rheumatology (Oxford)
; 56(4): 541-549, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28013198
11.
The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey.
Clin Exp Rheumatol
; 35(3): 477-483, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28134086
12.
Update on biosimilars in rheumatology.
Inflammopharmacology
; 25(2): 177-184, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28265837
13.
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.
Ann Rheum Dis
; 75(1): 3-15, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25969430
14.
Evaluating the patient with low back pain.
Practitioner
; 259(1788): 21-4, 2-3, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26882775
15.
Early treatment of psoriatic arthritis improves prognosis.
Practitioner
; 258(1777): 21-4, 3, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25603589
16.
Early recognition improves prognosis in elderly onset RA. .
Practitioner
; 258(1767): 11-4, 2, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24617098
17.
Self-management pivotal in osteoarthritis.
Practitioner
; 258(1770): 25-8, 3, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24881169
18.
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Rheumatol Ther
; 11(3): 633-648, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498139
19.
Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.
Circulation
; 126(21): 2473-80, 2012 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23095282
20.
Pulmonary complications of biological therapies in children and adults with rheumatic diseases.
Paediatr Respir Rev
; 14(4): 236-41, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23462434